Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver.

Okamoto K, Ishiguro T, Midorikawa Y, Ohata H, Izumiya M, Tsuchiya N, Sato A, Sakai H, Nakagama H.

EMBO J. 2012 Apr 4;31(7):1752-63. doi: 10.1038/emboj.2012.25. Epub 2012 Feb 28.

2.

MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells.

Sakai H, Sato A, Aihara Y, Ikarashi Y, Midorikawa Y, Kracht M, Nakagama H, Okamoto K.

Cancer Sci. 2014 Apr;105(4):425-30. doi: 10.1111/cas.12380. Epub 2014 Mar 24.

3.

MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.

Zhao X, Dou W, He L, Liang S, Tie J, Liu C, Li T, Lu Y, Mo P, Shi Y, Wu K, Nie Y, Fan D.

Oncogene. 2013 Mar 14;32(11):1363-72. doi: 10.1038/onc.2012.156. Epub 2012 May 21.

PMID:
22614005
4.

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.

Oncogene. 2012 Jul 12;31(28):3357-69. doi: 10.1038/onc.2011.500. Epub 2011 Nov 7.

PMID:
22056881
5.

MicroRNA expression profiles in human colorectal cancers with liver metastases.

Lin M, Chen W, Huang J, Gao H, Ye Y, Song Z, Shen X.

Oncol Rep. 2011 Mar;25(3):739-47. doi: 10.3892/or.2010.1112. Epub 2010 Dec 20.

PMID:
21174058
6.

MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.

Keklikoglou I, Koerner C, Schmidt C, Zhang JD, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T, Schneeweiss A, Sahin O, Wiemann S, Tschulena U.

Oncogene. 2012 Sep 13;31(37):4150-63. doi: 10.1038/onc.2011.571. Epub 2011 Dec 12.

PMID:
22158050
7.

Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer.

Takeyama H, Yamamoto H, Yamashita S, Wu X, Takahashi H, Nishimura J, Haraguchi N, Miyake Y, Suzuki R, Murata K, Ohue M, Kato T, Takemasa I, Mizushima T, Ishii H, Mimori K, Doki Y, Mori M.

Mol Cancer Ther. 2014 Apr;13(4):976-85. doi: 10.1158/1535-7163.MCT-13-0571. Epub 2014 Jan 21.

8.

MicroRNA-192 suppresses liver metastasis of colon cancer.

Geng L, Chaudhuri A, Talmon G, Wisecarver JL, Are C, Brattain M, Wang J.

Oncogene. 2014 Nov 13;33(46):5332-40. doi: 10.1038/onc.2013.478. Epub 2013 Nov 11.

9.

Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.

Lu MH, Huang CC, Pan MR, Chen HH, Hung WC.

Clin Cancer Res. 2012 Dec 1;18(23):6416-25. doi: 10.1158/1078-0432.CCR-12-0832. Epub 2012 Oct 8.

10.

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M.

BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374.

11.

A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.

Maurel M, Jalvy S, Ladeiro Y, Combe C, Vachet L, Sagliocco F, Bioulac-Sage P, Pitard V, Jacquemin-Sablon H, Zucman-Rossi J, Laloo B, Grosset CF.

Hepatology. 2013 Jan;57(1):195-204. doi: 10.1002/hep.25994.

PMID:
22865282
12.

The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.

Tokarz P, Blasiak J.

Acta Biochim Pol. 2012;59(4):467-74. Epub 2012 Nov 21. Review.

13.

Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.

Patel JB, Appaiah HN, Burnett RM, Bhat-Nakshatri P, Wang G, Mehta R, Badve S, Thomson MJ, Hammond S, Steeg P, Liu Y, Nakshatri H.

Oncogene. 2011 Mar 17;30(11):1290-301. doi: 10.1038/onc.2010.510. Epub 2010 Nov 8.

PMID:
21057539
14.

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A.

J Pathol. 2009 Oct;219(2):214-21. doi: 10.1002/path.2586.

PMID:
19593777
15.

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.

Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R.

Clin Cancer Res. 2011 Aug 15;17(16):5287-98. doi: 10.1158/1078-0432.CCR-10-2619. Epub 2010 Dec 15.

16.

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.

Zhang X, Liu S, Hu T, Liu S, He Y, Sun S.

Hepatology. 2009 Aug;50(2):490-9. doi: 10.1002/hep.23008.

PMID:
19472311
17.

The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.

Takei Y, Takigahira M, Mihara K, Tarumi Y, Yanagihara K.

Cancer Res. 2011 Feb 15;71(4):1442-53. doi: 10.1158/0008-5472.CAN-10-2530. Epub 2010 Dec 17.

18.

MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin.

Sun JY, Huang Y, Li JP, Zhang X, Wang L, Meng YL, Yan B, Bian YQ, Zhao J, Wang WZ, Yang AG, Zhang R.

Biochem Biophys Res Commun. 2012 Apr 20;420(4):787-92. doi: 10.1016/j.bbrc.2012.03.075. Epub 2012 Mar 20.

PMID:
22459450
19.

Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.

Jia Y, Liu H, Zhuang Q, Xu S, Yang Z, Li J, Lou J, Zhang W.

Oncol Rep. 2012 Jun;27(6):1865-72. doi: 10.3892/or.2012.1701. Epub 2012 Feb 28.

PMID:
22378186
20.

MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells.

Wang Z, Zhang X, Yang Z, Du H, Wu Z, Gong J, Yan J, Zheng Q.

Biochem Biophys Res Commun. 2012 Oct 26;427(3):444-9. doi: 10.1016/j.bbrc.2012.06.123. Epub 2012 Jul 2.

PMID:
22766504

Supplemental Content

Support Center